Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 studyMarina Elena Cazzaniga, Massimiliano Mazza, Anna Gambaro et al.|The Breast|2019Cited by 58
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 studyMarina Elena Cazzaniga, I. Vallini, Emilia Montagna et al.|Breast Cancer Research and Treatment|2021Cited by 17
The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA studyChiara Molinelli, Lucia Del Mastro, Marco Bruzzone et al.|European Journal of Cancer|2024Cited by 15
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patientsB. Trevisan, Francesca Fulvia Pepe, I. Vallini et al.|Scientific Reports|2023Cited by 5
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancerLinda Cucciniello, Fabio Puglisi, Eva Blondeaux et al.|npj Breast Cancer|2024Cited by 2